Helen Sabzevari, President and CEO at PRECIGEN, INC. (PGEN), sold 346,836 shares at $5.89 ($2.0M) on 2026-06-29, disclosed to the SEC on 2026-07-01.
Scheduled sale ($2.0M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PGEN | SELL | 2023-08-18 | $185K | — | Filing → |
| PGEN | SELL | 2023-08-11 | $119K | — | Filing → |
| PGEN | SELL | 2023-08-04 | $116K | — | Filing → |